Alterity announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials February 9, 2021August 16, 2022
Prana Biotechnology Investor Presentation and Audio Recording – Phase 2 HD trial February 18, 2014August 16, 2022